Full View

Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism

KM Egan, M Wang, MB Lucitt, AM Zukas, E Puré… - Circulation, 2005 - Am Heart Assoc
Background—Antagonism or deletion of the receptor (the TP) for the cyclooxygenase (COX)
product thromboxane (Tx) A2, retards atherogenesis in apolipoprotein E knockout (ApoE …
被引用次数：241 相关文章

Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism

KM Egan, M Wang, S Fries, MB Lucitt… - …, 2005 - pubmed.ncbi.nlm.nih.gov
Background Antagonism or deletion of the receptor (the TP) for the cyclooxygenase (COX)
product thromboxane (Tx) A2, retards atherogenesis in apolipoprotein E knockout (ApoE …

[引用][C] Cyclooxygenases, thromboxane, and atherosclerosis: Plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism

KM EGAN, M WANG, MB LUCITT… - … (New York, NY), 2005 - pascal-francis.inist.fr
Cyclooxygenases, thromboxane, and atherosclerosis: Plaque destabilization by cyclooxygenase-2
inhibition combined with thromboxane receptor antagonism CNRS Inist Pascal-Francis CNRS …

Cyclooxygenases, Thromboxane, and Atherosclerosis

KM Egan, M Wang, MB Lucitt, AM Zukas, E Puré… - Circulation, 2005 - cir.nii.ac.jp
抄録< jats: p>< jats: bold>< jats: italic> Background—</jats: italic></jats: bold> Antagonism
or deletion of the receptor (the TP) for the cyclooxygenase (COX) product thromboxane (Tx) …

Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.

KM Egan, M Wang, S Fries, MB Lucitt, AM Zukas… - Circulation, 2005 - europepmc.org
Background Antagonism or deletion of the receptor (the TP) for the cyclooxygenase (COX)
product thromboxane (Tx) A2, retards atherogenesis in apolipoprotein E knockout (ApoE …

[引用][C] Cyclooxygenases, thromboxane, and atherosclerosis: Plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism

KM EGAN, M WANG, MB LUCITT… - …, 2005 - Lippincott Williams & Wilkins